摘要
非洲和美洲人类锥虫病是一种病媒传播的寄生虫病,在早期已经杀死了数百万人,但仍有许多人患有这些被忽视的疾病。这些感染的病原体是锥虫属的寄生原生动物。目前针对这些地方病的治疗方案在安全性、有效性、给药途径方面存在一些局限性,并且其中一些由于各自寄生虫中出现耐药性而失去了疗效。在这篇综述中,强调了通过针对这些被忽视疾病的不同药物开发策略(包括基于靶点的方法、表型高通量筛选、药物再利用方法和联合治疗)确定的最有希望的化合物。目前正在进行临床前或临床研究的强效杂环化合物也已被评估,以确定一类有效的有机化合物,对这些热带疾病具有显着的治疗潜力。概述基序的分子杂交可能会产生更多活性化合物,并在未来避免特定目标产生抗性。
关键词: 人类非洲锥虫病、恰加斯病、病原体、治疗方案、药物开发、克氏锥虫。
Current Medicinal Chemistry
Title:Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis
Volume: 28 Issue: 36
关键词: 人类非洲锥虫病、恰加斯病、病原体、治疗方案、药物开发、克氏锥虫。
摘要: Human African and American trypanosomiasis are the vector-borne parasitic diseases that have killed millions of people early, and many people are yet suffering from these neglected diseases. The causative agents of these infections are parasitic protozoans of the genus Trypanosoma. Current treatment regimens against these endemic diseases have several limitations in terms of safety, efficacy, route of administration, and some of them have lost efficacy due to the emergence of resistance in their respective parasites. In this review, the most promising compounds identified by different strategies of drug development against these neglected diseases including target-based approach, the phenotypic high-throughput screening, the drug repurposing approach and combination therapy are emphasized. The potent heterocyclic compounds currently undergoing pre-clinical or clinical studies have also been assessed to ascertain an effective class of organic compounds having significant therapeutic potential against these tropical diseases. The molecular hybridization of outlined motifs may result in more active compounds and circumvent the development of resistance by specific targets in future.
Export Options
About this article
Cite this article as:
Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis, Current Medicinal Chemistry 2021; 28 (36) . https://dx.doi.org/10.2174/0929867328666210504111442
DOI https://dx.doi.org/10.2174/0929867328666210504111442 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TRPC Channels and their Implications for Neurological Diseases
CNS & Neurological Disorders - Drug Targets Bone and the Kidney: A Systems Biology Approach to the Molecular Mechanisms of Renal Osteodystrophy
Current Molecular Medicine TGFb and its Smad Connection to Cancer
Current Genomics The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema
Current Molecular Medicine Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Mini-Reviews in Medicinal Chemistry Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier
Current Cancer Drug Targets Wound-Associated Skin Fibrosis: Mechanisms and Treatments Based on Modulating the Inflammatory Response
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeted Therapies in Combination with Radiotherapy in Oesophageal and Gastroesophageal Carcinoma
Current Medicinal Chemistry Serial Analysis of Gene Expression in Eukaryotic Pathogens
Infectious Disorders - Drug Targets Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Current Pharmaceutical Design Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets Ascaris lumbricoides: An Overview of Therapeutic Targets
Infectious Disorders - Drug Targets Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry Micronutrient Intake in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity
Current Aging Science Induced Pluripotent Stem Cells as a Model for Therapy Personalization of Pediatric Patients: Disease Modeling and Drug Adverse Effects Prevention
Current Medicinal Chemistry The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Current Clinical Pharmacology Training Children to Reduce Motion and Increase Success of MRI Scanning
Current Medical Imaging